Is Pharma Doing Enough To Enable Access To COVID-19 Vaccines Everywhere?
Vaccine Efforts Falling Short In Low- and Middle-Income Countries
The race to develop COVID-19 vaccines is intensifying long-standing debate over the ability of lower-income countries to gain affordable access to needed medical treatments. Patient advocates argue that drug makers and wealthy governments are striking deals that place poor countries at a disadvantage. The pharmaceutical industry, however, maintains it is moving as quickly as possible to not only discover safe and effective vaccines, but to enable equitable distribution.
